AGP Executive Report
Last update: 7 hours agoPharma Regulation: India’s CDSCO clarified how modified- and sustained-release drug intermediates can be licensed—new drugs need marketing permission, while certain granules may go through state licensing, with extra rules for novel excipients. Digital Health & Marketing: TRUE Addiction and Behavioral Health partnered with Web Logix Group to expand access using an AI-powered healthcare growth platform. Public Health Access: Telangana’s revamped Employees Health Scheme launches July 15, with new operational guidelines, updated hospital/package planning, and a change to how contributions are deducted for dual-employee couples. Clinical Innovation: FDA approved Viridian Therapeutics’ Lumvoa (veligrotug-vvze) for thyroid eye disease across active and chronic stages, backed by two phase 3 trials. Care Delivery: Lumbini Province Hospital introduced emergency triage labels (red/yellow/green) to speed treatment for critical cases amid high daily patient volumes. Patient Safety Tech: A fast 13-second eye test using late pupillary response may help predict consciousness recovery after severe brain injury. Medication Safety in Heat: UKHSA warned that common drugs—including diuretics, beta-blockers, and SSRIs—can raise heat illness risk. Lifestyle & Weight: A study argues diet matters more than exercise for weight loss, and another highlights that under-50s show faster biological ageing tied to rising early cancers.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.